Ameriprise Financial Inc Avadel Pharmaceuticals PLC Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.55 - $17.22 $27,108 - $37,195	2,160 Added 0.75%	291,274 $4.92 Million
Q4 2023 Feb 14, 2024	BUY	$9.64 - $14.59 $39,533 - $59,833	4,101 Added 1.44%	289,114 $4.08 Million
Q3 2023 Nov 14, 2023	BUY	$10.3 - $15.99 $240,340 - $373,110	23,334 Added 8.92%	285,013 $2.94 Million
Q2 2023 Aug 14, 2023	BUY	$8.48 - $16.48 $348,392 - $677,064	41,084 Added 18.62%	261,679 $4.31 Million
Q1 2023 May 15, 2023	BUY	$6.41 - $9.95 $605,238 - $939,488	94,421 Added 74.83%	220,595 $2.02 Million
Q4 2022 Feb 14, 2023	BUY	$5.02 - $10.0 $164,123 - $326,940	32,694 Added 34.97%	126,174 $903,000
Q3 2022 Nov 14, 2022	SELL	$2.57 - $7.31 $47,290 - $134,511	-18,401 Reduced 16.45%	93,480 $468,000
Q2 2022 Aug 15, 2022	SELL	$1.07 - $6.95 $18,155 - $117,927	-16,968 Reduced 13.17%	111,881 $273,000
Q1 2022 May 16, 2022	SELL	$5.46 - $8.29 $73,174 - $111,102	-13,402 Reduced 9.42%	128,849 $880,000
Q4 2021 Feb 14, 2022	SELL	$7.34 - $11.18 $1.93 Million - $2.94 Million	-263,400 Reduced 64.93%	142,251 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$6.49 - $9.91 $44,755 - $68,339	6,896 Added 1.73%	405,651 $3.98 Million
Q2 2021 Aug 16, 2021	BUY	$6.73 - $9.05 $7,012 - $9,430	1,042 Added 0.26%	398,755 $2.7 Million
Q1 2021 May 17, 2021	BUY	$6.61 - $10.07 $158,164 - $240,954	23,928 Added 6.4%	397,713 $3.57 Million
Q4 2020 Feb 12, 2021	SELL	$5.03 - $7.95 $8,249 - $13,038	-1,640 Reduced 0.44%	373,785 $2.5 Million
Q3 2020 Nov 16, 2020	BUY	$5.02 - $8.98 $160,138 - $286,462	31,900 Added 9.29%	375,425 $1.89 Million
Q2 2020 Aug 14, 2020	SELL	$7.25 - $11.75 $670,588 - $1.09 Million	-92,495 Reduced 21.21%	343,525 $2.78 Million
Q1 2020 May 15, 2020	SELL	$4.06 - $10.64 $180,426 - $472,841	-44,440 Reduced 9.25%	436,020 $3.46 Million
Q4 2019 Feb 14, 2020	SELL	$3.34 - $7.7 $948,927 - $2.19 Million	-284,110 Reduced 37.16%	480,460 $3.63 Million
Q3 2019 Nov 14, 2019	BUY	$1.92 - $4.47 $49,152 - $114,432	25,600 Added 3.46%	764,570 $3.18 Million
Q2 2019 Aug 14, 2019	BUY	$1.09 - $3.19 $220,037 - $643,962	201,869 Added 37.58%	738,970 $2.14 Million
Q1 2019 May 15, 2019	BUY	$1.44 - $3.29 $47,852 - $109,329	33,231 Added 6.6%	537,101 $773,000
Q4 2018 Feb 14, 2019	BUY	$1.74 - $4.66 $315,435 - $844,788	181,285 Added 56.2%	503,870 $1.3 Million
Q3 2018 Nov 14, 2018	BUY	$4.08 - $7.14 $25,585 - $44,774	6,271 Added 1.98%	322,585 $1.41 Million
Q2 2018 Aug 14, 2018	BUY	$5.89 - $7.78 $452,251 - $597,371	76,783 Added 32.06%	316,314 $1.93 Million
Q1 2018 May 15, 2018	BUY	$6.76 - $11.7 $182,607 - $316,052	27,013 Added 12.71%	239,531 $1.74 Million
Q4 2017 Feb 12, 2018	BUY	$8.03 - $11.25 $67,050 - $93,937	8,350 Added 4.09%	212,518 $1.73 Million
Q3 2017 Nov 07, 2017	BUY	$8.35 - $10.5 $1.7 Million - $2.14 Million	204,168	204,168 $2.14 Million

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account